Zimmer Biomet Holdings, Inc. vs Abbvie Inc.
ZBH vs ABBV — side-by-side comparison from reported financials. ZBH leads 5, ABBV leads 7 of 12 comparable metrics.
Zimmer Biomet Holdings, Inc.
ZBH · Healthcare
$89.00+0.14%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ZBH | ABBV |
|---|---|---|
| Price | $89.00 | $276.43 |
| Market cap | $17.0B | $488B |
| Revenue (TTM) | $8.51B | $64.4B |
| Revenue growth | +5.8% | +1.8% |
| Net margin | 9.5% | 9.8% |
| Free cash flow | $1.52B | $18.2B |
| Net cash (debt) | ($6.34B) | ($56.2B) |
| 1-year price return | -8.6% | +19.8% |
| P/E | 21.5 | 77.4 |
| P/E vs own history (cheap-side %) | 96% | 23% |
| Dividend yield | 1.09% | 2.45% |
| Return on equity | 6% | 96% |
| Altman Z-score | 2.15 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 17,000 | 57,000 |
Full résumé-style profiles: ZBH CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.